Mereo Biopharma
Biopharmaceutical company focussed on the acquisition and rapid development of innovative medicines that have the potential to transform patient quality of life and improve human health. Learn more
Launch date
Employees
Market cap
CAD920m
Enterprise valuation
CAD809m (Public information from Sep 2024)
Share price
$4.28 MREO
Company register number 09481161
London England (HQ)
Authorizing premium user...